Clinical Trial Update: Effect of Miglustat on the Nasal Potential Difference in Patients With Cystic Fibrosis Homozygous for the F508del Mutation [Phase 2, Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 2/3 trial assessing miglustat's effect on nasal potential difference in cystic fibrosis patients homozygous for th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Miglustat (miglustat)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Cystic Fibrosis | Phase 2, Phase 3 | Status: COMPLETED